No Data
No Data
PYC Therapeutics Issues Stock Options
Express News | Lord David Prior Appointed as Chair of E-Therapeutics’ Board of Directors
Dyne Therapeutics Insider Sold Shares Worth $1,002,751, According to a Recent SEC Filing
Oxana Beskrovnaya, Chief Scientific Officer, on May 20, 2024, sold 30,426 shares in Dyne Therapeutics (DYN) for $1,002,751. Following the Form 4 filing with the SEC, Beskrovnaya has control over a tot
Roquefort Therapeutics Strengthens Finances & Leadership
Arecor Therapeutics Grants New Managerial Options
Roquefort Therapeutics Inks Major Licensing Deal
No Data